1. Home
  2. DNUT vs AVDL Comparison

DNUT vs AVDL Comparison

Compare DNUT & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNUT
  • AVDL
  • Stock Information
  • Founded
  • DNUT 1937
  • AVDL 2015
  • Country
  • DNUT United States
  • AVDL Ireland
  • Employees
  • DNUT N/A
  • AVDL N/A
  • Industry
  • DNUT Food Chains
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • DNUT Consumer Staples
  • AVDL Health Care
  • Exchange
  • DNUT Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • DNUT 720.4M
  • AVDL 784.6M
  • IPO Year
  • DNUT 2021
  • AVDL 1996
  • Fundamental
  • Price
  • DNUT $4.15
  • AVDL $8.03
  • Analyst Decision
  • DNUT Buy
  • AVDL Strong Buy
  • Analyst Count
  • DNUT 7
  • AVDL 7
  • Target Price
  • DNUT $12.29
  • AVDL $18.86
  • AVG Volume (30 Days)
  • DNUT 3.6M
  • AVDL 1.1M
  • Earning Date
  • DNUT 05-08-2025
  • AVDL 05-07-2025
  • Dividend Yield
  • DNUT 3.52%
  • AVDL N/A
  • EPS Growth
  • DNUT N/A
  • AVDL N/A
  • EPS
  • DNUT 0.02
  • AVDL N/A
  • Revenue
  • DNUT $1,665,397,000.00
  • AVDL $169,117,000.00
  • Revenue This Year
  • DNUT N/A
  • AVDL $50.53
  • Revenue Next Year
  • DNUT $11.91
  • AVDL $32.33
  • P/E Ratio
  • DNUT $231.46
  • AVDL N/A
  • Revenue Growth
  • DNUT N/A
  • AVDL 504.79
  • 52 Week Low
  • DNUT $3.91
  • AVDL $6.38
  • 52 Week High
  • DNUT $14.10
  • AVDL $19.09
  • Technical
  • Relative Strength Index (RSI)
  • DNUT 32.03
  • AVDL 54.47
  • Support Level
  • DNUT $3.91
  • AVDL $6.38
  • Resistance Level
  • DNUT $4.37
  • AVDL $8.22
  • Average True Range (ATR)
  • DNUT 0.32
  • AVDL 0.48
  • MACD
  • DNUT 0.04
  • AVDL 0.11
  • Stochastic Oscillator
  • DNUT 21.52
  • AVDL 89.67

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: